Studies of glucoCEST in patients with Alzheimer’s disease are still missing, however they have been conducted in animal models focused on either Aβ-related pathology (APP23, AD-Aβ25–35, and APP/PS1) or tauopathy (rTg4510 or Tau4RΔK) [130,178,179,180,181] (Table 6). The gene discussed is APP; the disease is Alzheimer disease.